171 related articles for article (PubMed ID: 23823800)
1. Effects of calorie restriction and IGF-1 receptor blockade on the progression of 22Rv1 prostate cancer xenografts.
Galet C; Gray A; Said JW; Castor B; Wan J; Beltran PJ; Calzone FJ; Elashoff D; Cohen P; Aronson WJ
Int J Mol Sci; 2013 Jul; 14(7):13782-95. PubMed ID: 23823800
[TBL] [Abstract][Full Text] [Related]
2. Effect of a low-fat diet combined with IGF-1 receptor blockade on 22Rv1 prostate cancer xenografts.
Konijeti R; Koyama S; Gray A; Barnard RJ; Said JW; Castor B; Elashoff D; Wan J; Beltran PJ; Calzone FJ; Cohen P; Galet C; Aronson WJ
Mol Cancer Ther; 2012 Jul; 11(7):1539-46. PubMed ID: 22562985
[TBL] [Abstract][Full Text] [Related]
3. Targeting IGF-IR with ganitumab inhibits tumorigenesis and increases durability of response to androgen-deprivation therapy in VCaP prostate cancer xenografts.
Fahrenholtz CD; Beltran PJ; Burnstein KL
Mol Cancer Ther; 2013 Apr; 12(4):394-404. PubMed ID: 23348048
[TBL] [Abstract][Full Text] [Related]
4. A novel calcium-dependent mechanism of acquired resistance to IGF-1 receptor inhibition in prostate cancer cells.
Fahrenholtz CD; Greene AM; Beltran PJ; Burnstein KL
Oncotarget; 2014 Oct; 5(19):9007-21. PubMed ID: 25344862
[TBL] [Abstract][Full Text] [Related]
5. Ganitumab (AMG 479) inhibits IGF-II-dependent ovarian cancer growth and potentiates platinum-based chemotherapy.
Beltran PJ; Calzone FJ; Mitchell P; Chung YA; Cajulis E; Moody G; Belmontes B; Li CM; Vonderfecht S; Velculescu VE; Yang G; Qi J; Slamon DJ; Konecny GE
Clin Cancer Res; 2014 Jun; 20(11):2947-58. PubMed ID: 24727326
[TBL] [Abstract][Full Text] [Related]
6. Effect of intermittent fasting on prostate cancer tumor growth in a mouse model.
Thomas JA; Antonelli JA; Lloyd JC; Masko EM; Poulton SH; Phillips TE; Pollak M; Freedland SJ
Prostate Cancer Prostatic Dis; 2010 Dec; 13(4):350-5. PubMed ID: 20733612
[TBL] [Abstract][Full Text] [Related]
7. Caloric restriction counteracts chemotherapy-induced inflammation and increases response to therapy in a triple negative breast cancer model.
Simone BA; Palagani A; Strickland K; Ko K; Jin L; Lim MK; Dan TD; Sarich M; Monti DA; Cristofanilli M; Simone NL
Cell Cycle; 2018; 17(13):1536-1544. PubMed ID: 29912618
[TBL] [Abstract][Full Text] [Related]
8. In vivo effects of the human type I insulin-like growth factor receptor antibody A12 on androgen-dependent and androgen-independent xenograft human prostate tumors.
Wu JD; Odman A; Higgins LM; Haugk K; Vessella R; Ludwig DL; Plymate SR
Clin Cancer Res; 2005 Apr; 11(8):3065-74. PubMed ID: 15837762
[TBL] [Abstract][Full Text] [Related]
9. Dose-dependent effects of calorie restriction on gene expression, metabolism, and tumor progression are partially mediated by insulin-like growth factor-1.
Nogueira LM; Lavigne JA; Chandramouli GV; Lui H; Barrett JC; Hursting SD
Cancer Med; 2012 Oct; 1(2):275-88. PubMed ID: 23342276
[TBL] [Abstract][Full Text] [Related]
10. Epitope-specific mechanisms of IGF1R inhibition by ganitumab.
Calzone FJ; Cajulis E; Chung YA; Tsai MM; Mitchell P; Lu J; Chen C; Sun J; Radinsky R; Kendall R; Beltran PJ
PLoS One; 2013; 8(2):e55135. PubMed ID: 23383308
[TBL] [Abstract][Full Text] [Related]
11. Growth inhibition of human prostate cancer cells in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice by a ligand-specific antibody to human insulin-like growth factors.
Goya M; Miyamoto S; Nagai K; Ohki Y; Nakamura K; Shitara K; Maeda H; Sangai T; Kodama K; Endoh Y; Ishii G; Hasebe T; Yonou H; Hatano T; Ogawa Y; Ochiai A
Cancer Res; 2004 Sep; 64(17):6252-8. PubMed ID: 15342412
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of ganitumab (AMG 479), alone and in combination with rapamycin, in Ewing's and osteogenic sarcoma models.
Beltran PJ; Chung YA; Moody G; Mitchell P; Cajulis E; Vonderfecht S; Kendall R; Radinsky R; Calzone FJ
J Pharmacol Exp Ther; 2011 Jun; 337(3):644-54. PubMed ID: 21385891
[TBL] [Abstract][Full Text] [Related]
13. Combined Inhibition of IGF-1R/IR and Src family kinases enhances antitumor effects in prostate cancer by decreasing activated survival pathways.
Dayyani F; Parikh NU; Varkaris AS; Song JH; Moorthy S; Chatterji T; Maity SN; Wolfe AR; Carboni JM; Gottardis MM; Logothetis CJ; Gallick GE
PLoS One; 2012; 7(12):e51189. PubMed ID: 23300537
[TBL] [Abstract][Full Text] [Related]
14. Combination of anti-IGF-1R antibody A12 and ionizing radiation in upper respiratory tract cancers.
Riesterer O; Yang Q; Raju U; Torres M; Molkentine D; Patel N; Valdecanas D; Milas L; Ang KK
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1179-87. PubMed ID: 21129859
[TBL] [Abstract][Full Text] [Related]
15. 15-lipoxygenase-1 expression upregulates and activates insulin-like growth factor-1 receptor in prostate cancer cells.
Kelavkar UP; Cohen C
Neoplasia; 2004; 6(1):41-52. PubMed ID: 15068670
[TBL] [Abstract][Full Text] [Related]
16. IGF-1R and mTOR Blockade: Novel Resistance Mechanisms and Synergistic Drug Combinations for Ewing Sarcoma.
Lamhamedi-Cherradi SE; Menegaz BA; Ramamoorthy V; Vishwamitra D; Wang Y; Maywald RL; Buford AS; Fokt I; Skora S; Wang J; Naing A; Lazar AJ; Rohren EM; Daw NC; Subbiah V; Benjamin RS; Ratan R; Priebe W; Mikos AG; Amin HM; Ludwig JA
J Natl Cancer Inst; 2016 Dec; 108(12):. PubMed ID: 27576731
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor 1 receptor regulates hypothermia during calorie restriction.
Cintron-Colon R; Sanchez-Alavez M; Nguyen W; Mori S; Gonzalez-Rivera R; Lien T; Bartfai T; Aïd S; François JC; Holzenberger M; Conti B
Proc Natl Acad Sci U S A; 2017 Sep; 114(36):9731-9736. PubMed ID: 28827363
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor-type 1 receptor inhibitor NVP-AEW541 enhances radiosensitivity of PTEN wild-type but not PTEN-deficient human prostate cancer cells.
Isebaert SF; Swinnen JV; McBride WH; Haustermans KM
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):239-47. PubMed ID: 21816290
[TBL] [Abstract][Full Text] [Related]
19. IGF1R blockade with ganitumab results in systemic effects on the GH-IGF axis in mice.
Moody G; Beltran PJ; Mitchell P; Cajulis E; Chung YA; Hwang D; Kendall R; Radinsky R; Cohen P; Calzone FJ
J Endocrinol; 2014 Apr; 221(1):145-55. PubMed ID: 24492468
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of insulin-like growth factor binding protein-3 by apigenin leads to growth inhibition and apoptosis of 22Rv1 xenograft in athymic nude mice.
Shukla S; Mishra A; Fu P; MacLennan GT; Resnick MI; Gupta S
FASEB J; 2005 Dec; 19(14):2042-4. PubMed ID: 16230333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]